Thisadoldilok acting Director, Research Department
the SEC since 1993, Tipsuda has extensive experience in market and intermediaries supervisions and development, research and strategic planning. Moreover, she has had prominent roles in Capital Market
จาก Lao Securities Commission Office (LSCO) Lao Securities Exchange (LSX) Japan International Cooperation Agency (JICA) Laos Office และ Nomura Research Institute (NRI) Thailand ในโครงการ “Study Visit on
million baht. Cash Flow The Company’s net operating cash flow dropped by 24.32 million baht. The net cash flow used for investment activities fell by 4.70 million baht, while the net cash flow from
Company Limited as of 31st December 2019 as follows: A. Book value B. Adjusted book value based on market value C. Discounted cash flow method Value of shares of Modern Pharma Company Limited based on
product division which included product research, legal & marketing, and marketing activations at the PGA tour event to launch CBG DEAN & DELUCA Performance Bar. CBG sales anticipated to show first results
12,416 12,811 Gross profit margin (%) 25.47% 26.48% 27.29% Consolidated financial ratios 2017 2016 2015 Financial data and profitability ratios (continuous) Operating expense (include Research and
of the last three financial years on issuer-sponsored research and development activities. D. Trend Information, Profit Forecast and Cash Flow Forecast 1. The issuer should discuss, for at least the
-party B-to-B research) achieved by chemical companies. EcoVadis awarded the Company its highest recognition, Gold, and ranked us among the Top 5% of performers and one of the most preferred suppliers